SIGA Technologies Inc adopts the new Arestvyr name for ST-246 

SIGA Technologies Inc adopts the new Arestvyr name for ST-246

Receives BARDA payment

Nov 30, 2012 (Menafn - M2 EQUITYBITES via COMTEX) --Pharmaceutical agents company SIGA Technologies Inc (nasdaqgm:SIGA) revealed on Thursday that its smallpox antiviral is now known under the new brand name,Arestvyr, for all purposes, including commercial sales and seeking full marketing approval of the antiviral as a smallpox treatment.

The company added that the smallpox antiviral was previously called ST-246.

In addition, the company has announced the receipt of USD12.3m in milestone, which was previously invoiced to the US government under SIGA's Strategic National Stockpile contract.

Comments on this story may be sent to info@m2.com

(C)1994-2012 M2 COMMUNICATIONS http://www.m2.com